ReviewDrugs in context2019

Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges.

Shinichi Makita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.